{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:18:57Z","timestamp":1790713137250,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009582","name":"NBIA Disorders Association","doi-asserted-by":"publisher","award":["559-D020-1016-21"],"award-info":[{"award-number":["559-D020-1016-21"]}],"id":[{"id":"10.13039\/100009582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024109","name":"Uniwersytet Gda\u0144ski","doi-asserted-by":"publisher","award":["531-D020-D242-25"],"award-info":[{"award-number":["531-D020-D242-25"]}],"id":[{"id":"10.13039\/501100024109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05479-z","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:57:17Z","timestamp":1763945837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Iron Dysregulation in Neurodegeneration with Brain Iron Accumulation (NBIA): Links between Mutations Occurring in BPAN, PKAN, MPAN and PLAN Types and Iron Metabolism"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-8123","authenticated-orcid":false,"given":"Karolina","family":"Wi\u015bniewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Szota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4758-1394","authenticated-orcid":false,"given":"Magdalena","family":"\u017babi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-8932","authenticated-orcid":false,"given":"Aneta","family":"Szulc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3746-8726","authenticated-orcid":false,"given":"\u0141ukasz","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-7466","authenticated-orcid":false,"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-6567","authenticated-orcid":false,"given":"Karolina","family":"Pierzynowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"5479_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.14034","volume":"8","author":"P Hogarth","year":"2015","unstructured":"Hogarth P (2015) Neurodegeneration with brain iron accumulation: diagnosis and management. JMD 8:1\u201313. https:\/\/doi.org\/10.14802\/jmd.14034","journal-title":"JMD"},{"key":"5479_CR2","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/brain\/awad357","volume":"147","author":"V Iankova","year":"2024","unstructured":"Iankova V, Sparber P, Rohani M et al (2024) Phenotype and natural history of mitochondrial membrane protein-associated neurodegeneration. Brain 147:1389\u20131398. https:\/\/doi.org\/10.1093\/brain\/awad357","journal-title":"Brain"},{"key":"5479_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13023-023-02869-1","volume":"18","author":"T Klopstock","year":"2023","unstructured":"Klopstock T, Mercimek-Andrews S, Jurecka A et al (2023) Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey. Orphanet J Rare Dis 18:257. https:\/\/doi.org\/10.1186\/s13023-023-02869-1","journal-title":"Orphanet J Rare Dis"},{"key":"5479_CR4","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/dmcn.14980","volume":"63","author":"JL Wilson","year":"2021","unstructured":"Wilson JL, Gregory A, Kurian MA et al (2021) Consensus clinical management guideline for beta-propeller protein-associated neurodegeneration. Dev Med Child Neurol 63:1402\u20131409. https:\/\/doi.org\/10.1111\/dmcn.14980","journal-title":"Dev Med Child Neurol"},{"key":"5479_CR5","doi-asserted-by":"publisher","unstructured":"Gregory A, Lotia M, Jeong SY, Fox R, Zhen D, Sanford L, Hamada J, Jahic A, et al (2019) Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN). Mol Genet Genomic Med 7(7):e00736. https:\/\/doi.org\/10.1002\/mgg3.736","DOI":"10.1002\/mgg3.736"},{"key":"5479_CR6","doi-asserted-by":"publisher","unstructured":"Balicza P, Bencsik R, Lengyel A, Gal A, Grosz Z, Csaban D, Rudas G, Danics K, et al (2020) Novel dominant MPAN family with a complex genetic architecture as a basis for phenotypic variability. Neurol Genet 6(5):e515. https:\/\/doi.org\/10.1212\/NXG.0000000000000515","DOI":"10.1212\/NXG.0000000000000515"},{"issue":"3","key":"5479_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/jnc.15548","volume":"160","author":"L Aring","year":"2022","unstructured":"Aring L, Choi E-K, Kopera H, Choi E-K, Lanigan T, Iwase S, Klionsky DJ, Seo YA (2022) A neurodegeneration gene, WDR45, links impaired ferritinophagy to iron accumulation. J Neurochem 160(3):356\u2013375. https:\/\/doi.org\/10.1111\/jnc.15548","journal-title":"J Neurochem"},{"key":"5479_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/pharmaceutics15010267","volume":"15","author":"E Zanuttigh","year":"2023","unstructured":"Zanuttigh E, Derderian K, G\u00fcra MA et al (2023) Identification of autophagy as a functional target suitable for the pharmacological treatment of mitochondrial membrane protein-associated neurodegeneration (MPAN) in vitro. Pharmaceutics 15:267. https:\/\/doi.org\/10.3390\/pharmaceutics15010267","journal-title":"Pharmaceutics"},{"issue":"2","key":"5479_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.nbd.2010.04.009","volume":"39","author":"M Poli","year":"2010","unstructured":"Poli M, Derosas M, Luscieti S, Cavadini P, Campanella A, Verardi R, Finazzi D, Arosio P (2010) Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation. Neurobiol Dis 39(2):204\u2013210. https:\/\/doi.org\/10.1016\/j.nbd.2010.04.009","journal-title":"Neurobiol Dis"},{"key":"5479_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/B978-0-12-410502-7.00003-X","volume":"110","author":"MA Kurian","year":"2013","unstructured":"Kurian MA, Hayflick SJ (2013) Pantothenate Kinase-Associated Neurodegeneration (PKAN) and PLA2G6-Associated Neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes. Int Rev Neurobiol 110:49\u201371. https:\/\/doi.org\/10.1016\/B978-0-12-410502-7.00003-X","journal-title":"Int Rev Neurobiol"},{"key":"5479_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.904027","volume":"13","author":"Y Zou","year":"2022","unstructured":"Zou Y, Luo H, Yuan H, Xie K, Yang Y, Huang S, Yang B, Liu Y (2022) Identification of a novel nonsense mutation in PLA2G6 and prenatal diagnosis in a Chinese family with infantile neuroaxonal dystrophy. Front Neurol 13:904027. https:\/\/doi.org\/10.3389\/fneur.2022.904027","journal-title":"Front Neurol"},{"key":"5479_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1469-8749.2011.03955.x","volume":"53","author":"MA Kurian","year":"2011","unstructured":"Kurian MA, Mcneill A, Lin J-P, Maher ER (2011) Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev Med Child Neurol 53:394\u2013404. https:\/\/doi.org\/10.1111\/j.1469-8749.2011.03955.x","journal-title":"Dev Med Child Neurol"},{"key":"5479_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101957","volume":"89","author":"X Deng","year":"2023","unstructured":"Deng X, Yuan L, Jankovic J, Deng H (2023) The role of the PLA2G6 gene in neurodegenerative diseases. Ageing Res Rev 89:101957. https:\/\/doi.org\/10.1016\/j.arr.2023.101957","journal-title":"Ageing Res Rev"},{"key":"5479_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105477","volume":"112","author":"J Xue","year":"2023","unstructured":"Xue J, Ding D-X, Xu G-Y, Wang P-Z, Ge Y-L, Zhang J-R, Cheng X-Y, Wang Y-M, et al (2023) A systematic analysis of genotype\u2013phenotype associations with PLA2G6. Parkinsonism Relat Disord 112:105477. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105477","journal-title":"Parkinsonism Relat Disord"},{"key":"5479_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107114","volume":"202","author":"J Liu","year":"2024","unstructured":"Liu J, Tan J, Tang B, Guo J (2024) Unveiling the role of iPLA2\u03b2 in neurodegeneration: from molecular mechanisms to advanced therapies. Pharmacol Res 202:107114. https:\/\/doi.org\/10.1016\/j.phrs.2024.107114","journal-title":"Pharmacol Res"},{"key":"5479_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainres.2019.01.036","volume":"1712","author":"Y-P Guo","year":"2019","unstructured":"Guo Y-P, Tang B-S, Liu H-L et al (2019) Impaired iPLA2\u03b2 activity affects iron uptake and storage without iron accumulation: an in vitro study excluding decreased iPLA2\u03b2 activity as the cause of iron deposition in PLAN. Brain Res 1712:25\u201333. https:\/\/doi.org\/10.1016\/j.brainres.2019.01.036","journal-title":"Brain Res"},{"key":"5479_CR17","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.neurobiolaging.2010.05.009","volume":"33","author":"C Pais\u00e1n-Ruiz","year":"2012","unstructured":"Pais\u00e1n-Ruiz C, Li A, Schneider SA et al (2012) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 33:814\u2013823. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.05.009","journal-title":"Neurobiol Aging"},{"issue":"10","key":"5479_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141629","volume":"10","author":"G Beck","year":"2015","unstructured":"Beck G, Shinzawa K, Hayakawa H, Baba K, Yasuda T, Sumi-Akamaru H, Tsujimoto Y, Mochizuki H (2015) Deficiency of calcium-independent phospholipase A2 beta induces brain iron accumulation through upregulation of divalent metal transporter 1. PLoS ONE 10(10):e0141629. https:\/\/doi.org\/10.1371\/journal.pone.0141629","journal-title":"PLoS ONE"},{"key":"5479_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ejpn.2018.01.008","volume":"22","author":"I Di Meo","year":"2018","unstructured":"Di Meo I, Tiranti V (2018) Classification and molecular pathogenesis of NBIA syndromes. Eur J Paediatr Neurol 22:272\u2013284. https:\/\/doi.org\/10.1016\/j.ejpn.2018.01.008","journal-title":"Eur J Paediatr Neurol"},{"key":"5479_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2017.00018","volume":"8","author":"R Ingrassia","year":"2017","unstructured":"Ingrassia R, Memo M, Garavaglia B (2017) Ferrous iron up-regulation in fibroblasts of patients with Beta propeller protein-associated neurodegeneration (BPAN). Front Genet 8:18. https:\/\/doi.org\/10.3389\/fgene.2017.00018","journal-title":"Front Genet"},{"issue":"21","key":"5479_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111650","volume":"22","author":"HE Lee","year":"2021","unstructured":"Lee HE, Jung MK, Noh SG, Choi HB, Chae SH, Lee JH, Mun JY (2021) Iron accumulation and changes in cellular organelles in WDR45 mutant fibroblasts. Int J Mol Sci 22(21):11650. https:\/\/doi.org\/10.3390\/ijms222111650","journal-title":"Int J Mol Sci"},{"key":"5479_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105649","volume":"165","author":"I Villalon","year":"2022","unstructured":"Villalon I, \u00c1lvarezC\u00f3doba M, Povea-Cabello S et al (2022) Vitamin E prevents lipid peroxidation and iron accumulation in PLA2G6-associated neurodegeneration. Neurobiol Dis 165:105649. https:\/\/doi.org\/10.1016\/j.nbd.2022.105649","journal-title":"Neurobiol Dis"},{"key":"5479_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2022.02.006","volume":"182","author":"C Shao","year":"2022","unstructured":"Shao C, Zhu J, Ma X, Siedlak SL, Cohen ML, Lerner A, Wang W (2022) C19orf12 ablation causes ferroptosis in mitochondrial membrane protein-associated with neurodegeneration. Free Radic Biol Med 182:23\u201333. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.02.006","journal-title":"Free Radic Biol Med"},{"key":"5479_CR24","doi-asserted-by":"publisher","first-page":"167541","DOI":"10.1016\/j.bbadis.2024.167541","volume":"1871","author":"A Wydrych","year":"2025","unstructured":"Wydrych A, Paku\u0142a B, Jakubek-Olszewska P et al (2025) Metabolic alterations in fibroblasts of patients presenting with the MPAN subtype of neurodegeneration with brain iron accumulation (NBIA). Biochimica et Biophysica Acta (BBA) - Molecul Basis Dis 1871:167541. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167541","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecul Basis Dis"},{"key":"5479_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.nbd.2015.02.030","volume":"81","author":"P Santambrogio","year":"2015","unstructured":"Santambrogio P, Dusi S, Guaraldo M, Rotundo LI, Broccoli V, Garavaglia B, Tiranti V, Levi S (2015) Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients. Neurobiol Dis 81:144\u2013153. https:\/\/doi.org\/10.1016\/j.nbd.2015.02.030","journal-title":"Neurobiol Dis"},{"key":"5479_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12011-019-01867-4","volume":"195","author":"J Che","year":"2020","unstructured":"Che J, Yang J, Zhao B et al (2020) The effect of abnormal iron metabolism on osteoporosis. Biol Trace Elem Res 195:353\u2013365. https:\/\/doi.org\/10.1007\/s12011-019-01867-4","journal-title":"Biol Trace Elem Res"},{"key":"5479_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/cells10020365","volume":"10","author":"K Pierzynowska","year":"2021","unstructured":"Pierzynowska K, Rintz E, Gaffke L, W\u0119grzyn G (2021) Ferroptosis and its modulation by autophagy in light of the pathogenesis of lysosomal storage diseases. Cells 10:365. https:\/\/doi.org\/10.3390\/cells10020365","journal-title":"Cells"},{"issue":"21","key":"5479_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213464","volume":"11","author":"MY Ali","year":"2022","unstructured":"Ali MY, Oliva CR, Flor S, Griguer CE (2022) Mitoferrin, cellular and mitochondrial iron homeostasis. Cells 11(21):3464. https:\/\/doi.org\/10.3390\/cells11213464","journal-title":"Cells"},{"key":"5479_CR29","doi-asserted-by":"publisher","first-page":"9314","DOI":"10.1038\/sj.onc.1208331","volume":"23","author":"T Proikas-Cezanne","year":"2004","unstructured":"Proikas-Cezanne T, Waddell S, Gaugel A et al (2004) WIPI-1alpha (WIPI49), a member of the novel 7-bladed WIPI protein family, is aberrantly expressed in human cancer and is linked to starvation-induced autophagy. Oncogene 23:9314\u20139325. https:\/\/doi.org\/10.1038\/sj.onc.1208331","journal-title":"Oncogene"},{"key":"5479_CR30","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1093\/brain\/awy230","volume":"141","author":"P Seibler","year":"2018","unstructured":"Seibler P, Burbulla LF, Dulovic M et al (2018) Iron overload is accompanied by mitochondrial and lysosomal dysfunction in WDR45 mutant cells. Brain 141:3052\u20133064. https:\/\/doi.org\/10.1093\/brain\/awy230","journal-title":"Brain"},{"key":"5479_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.645831","volume":"8","author":"Q Xiong","year":"2021","unstructured":"Xiong Q, Li X, Li W, Chen G, Xiao H, Li P, Wu C (2021) WDR45 mutation impairs the autophagic degradation of transferrin receptor and promotes ferroptosis. Front Mol Biosci 8:645831. https:\/\/doi.org\/10.3389\/fmolb.2021.645831","journal-title":"Front Mol Biosci"},{"key":"5479_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.redox.2017.08.015","volume":"14","author":"S Masaldan","year":"2018","unstructured":"Masaldan S, Clatworthy SAS, Gamell C et al (2018) Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox Biol 14:100\u2013115. https:\/\/doi.org\/10.1016\/j.redox.2017.08.015","journal-title":"Redox Biol"},{"key":"5479_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.freeradbiomed.2024.05.017","volume":"221","author":"HE Lee","year":"2024","unstructured":"Lee HE, Jung M, Choi K, Jang JH, Hwang S-K, Chae S, Lee J-H, Mun JY (2024) L-serine restored lysosomal failure in cells derived from patients with BPAN reducing iron accumulation with eliminating lipofuscin. Free Radic Biol Med 221:273\u2013282. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.05.017","journal-title":"Free Radic Biol Med"},{"key":"5479_CR34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41556-024-01373-3","volume":"26","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Fujimaki M, Snape L et al (2024) Loss of WIPI4 in neurodegeneration causes autophagy-independent ferroptosis. Nat Cell Biol 26:542\u2013551. https:\/\/doi.org\/10.1038\/s41556-024-01373-3","journal-title":"Nat Cell Biol"},{"key":"5479_CR35","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910489","volume":"11","author":"SY Jeong","year":"2019","unstructured":"Jeong SY, Hogarth P, Placzek A et al (2019) 4\u2032\u2010phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN. EMBO Mol Med 11:e10489. https:\/\/doi.org\/10.15252\/emmm.201910489","journal-title":"EMBO Mol Med"},{"key":"5479_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13023-021-01823-3","volume":"16","author":"M \u00c1lvarez-C\u00f3rdoba","year":"2021","unstructured":"\u00c1lvarez-C\u00f3rdoba M, Talaver\u00f3n-Rey M, Villal\u00f3n-Garc\u00eda I et al (2021) Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives. Orphanet J Rare Dis 16:201. https:\/\/doi.org\/10.1186\/s13023-021-01823-3","journal-title":"Orphanet J Rare Dis"},{"key":"5479_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107806","volume":"134","author":"J Zhu","year":"2025","unstructured":"Zhu J, Yao T, Wang C (2025) Mitochondrial and autophagic dysfunctions of skin fibroblasts derived from pantothenate kinase-associated neurodegeneration patients carrying PANK2 mutations and the rescuing effects of allantoin. Parkinsonism Relat Disord 134:107806. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107806","journal-title":"Parkinsonism Relat Disord"},{"key":"5479_CR38","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.15252\/emmm.201606391","volume":"8","author":"DI Orellana","year":"2016","unstructured":"Orellana DI, Santambrogio P, Rubio A et al (2016) Coenzyme A corrects pathological defects in human neurons of PANK2-associated neurodegeneration. EMBO Mol Med 8:1197\u20131211. https:\/\/doi.org\/10.15252\/emmm.201606391","journal-title":"EMBO Mol Med"},{"key":"5479_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41419-022-04626-x","volume":"13","author":"P Santambrogio","year":"2022","unstructured":"Santambrogio P, Ripamonti M, Cozzi A et al (2022) Massive iron accumulation in PKAN-derived neurons and astrocytes: light on the human pathological phenotype. Cell Death Dis 13:185. https:\/\/doi.org\/10.1038\/s41419-022-04626-x","journal-title":"Cell Death Dis"},{"key":"5479_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.freeradbiomed.2025.05.421","volume":"237","author":"Z Han","year":"2025","unstructured":"Han Z, Han S, Fang X, Lu M, Mao Y, Shi L, Song J, Wang T, et al. (2025) Acetyl-CoA carboxylase activation disrupts iron homeostasis to drive ferroptosis. Free Radic Biol Med 237:110\u2013130. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.05.421","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"5479_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ajhg.2011.09.007","volume":"89","author":"MB Hartig","year":"2011","unstructured":"Hartig MB, Iuso A, Haack T, Hartig M, Kmiec T, Jurkiewicz E, Heim K, Roeber S, et al (2011) Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet 89(4):543\u2013550. https:\/\/doi.org\/10.1016\/j.ajhg.2011.09.007","journal-title":"Am J Hum Genet"},{"issue":"2","key":"5479_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.spen.2012.03.006","volume":"19","author":"C Panteghini","year":"2012","unstructured":"Panteghini C, Zorzi G, Venco P, Dusi S, Reale C, Brunetti D, Chiapparini L, Zibordi F, et al (2012) C19orf12 and FA2H mutations are rare in Italian patients with neurodegeneration with brain iron accumulation. Semin Pediatr Neurol 19(2):75\u201381. https:\/\/doi.org\/10.1016\/j.spen.2012.03.006","journal-title":"Semin Pediatr Neurol"},{"key":"5479_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2015.00185","volume":"6","author":"P Venco","year":"2015","unstructured":"Venco P, Bonora M, Giorgi C, Papaleo E, Iuso A, Prokisch H, Pinton P, Tiranti V (2015) Mutations of C19orf12, coding for a transmembrane glycine zipper containing mitochondrial protein, cause mis-localization of the protein, inability to respond to oxidative stress and increased mitochondrial Ca2+. Front Genet 6:185. https:\/\/doi.org\/10.3389\/fgene.2015.00185","journal-title":"Front Genet"},{"issue":"2","key":"5479_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1011137","volume":"20","author":"P Sreejith","year":"2024","unstructured":"Sreejith P, Lolo S, Patten KR, Gunasinghe M, More N, Pallanck LJ, Bharadwaj R (2024) Nazo, the Drosophila homolog of the NBIA-mutated protein-c19orf12, is required for triglyceride homeostasis. PLoS Genet 20(2):e1011137. https:\/\/doi.org\/10.1371\/journal.pgen.1011137","journal-title":"PLoS Genet"},{"issue":"2","key":"5479_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089439","volume":"9","author":"A Iuso","year":"2014","unstructured":"Iuso A, Sibon OCM, Gorza M, Heim K, Organisti C, Meitinger T, Prokisch H (2014) Impairment of Drosophila orthologs of the human orphan protein C19orf12 induces bang sensitivity and neurodegeneration. PLoS ONE 9(2):e89439. https:\/\/doi.org\/10.1371\/journal.pone.0089439","journal-title":"PLoS ONE"},{"key":"5479_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.596069","volume":"8","author":"L Mignani","year":"2020","unstructured":"Mignani L, Zizioli D, Borsani G, Monti E, Finazzi D (2020) The downregulation of c19orf12 negatively affects neuronal and musculature development in zebrafish embryos. Front Cell Dev Biol 8:596069. https:\/\/doi.org\/10.3389\/fcell.2020.596069","journal-title":"Front Cell Dev Biol"},{"key":"5479_CR47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ajhg.2018.01.003","volume":"102","author":"A Drecourt","year":"2018","unstructured":"Drecourt A, Babdor J, Dussiot M et al (2018) Impaired transferrin receptor palmitoylation and recycling in neurodegeneration with brain iron accumulation. Am J Hum Genet 102:266\u2013277. https:\/\/doi.org\/10.1016\/j.ajhg.2018.01.003","journal-title":"Am J Hum Genet"},{"key":"5479_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105353","volume":"109","author":"H-Y Chen","year":"2023","unstructured":"Chen H-Y, Lin H-I, Hsu C-L, Chen P-L, Huang C-Y, Teng S-C, Lin C-H (2023) A novel C19orf12 frameshift mutation in a MPAN pedigree impairs mitochondrial function and connectivity leading to neurodegeneration. Parkinsonism Relat Disord 109:105353. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105353","journal-title":"Parkinsonism Relat Disord"},{"key":"5479_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/mds.23971","volume":"27","author":"SA Schneider","year":"2012","unstructured":"Schneider SA, Hardy J, Bhatia KP (2012) Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations. Mov Disord 27:42\u201353. https:\/\/doi.org\/10.1002\/mds.23971","journal-title":"Mov Disord"},{"issue":"1","key":"5479_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/ph12010027","volume":"12","author":"S Levi","year":"2019","unstructured":"Levi S, Tiranti V (2019) Neurodegeneration with brain iron accumulation disorders: valuable models aimed at understanding the pathogenesis of iron deposition. Pharmaceut (Basel) 12(1):27. https:\/\/doi.org\/10.3390\/ph12010027","journal-title":"Pharmaceut (Basel)"},{"key":"5479_CR51","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fneur.2018.00536","volume":"9","author":"R Ferese","year":"2018","unstructured":"Ferese R, Scala S, Biagioni F et al (2018) Heterozygous PLA2G6 mutation leads to iron accumulation within basal ganglia and Parkinson\u2019s disease. Front Neurol 9:536. https:\/\/doi.org\/10.3389\/fneur.2018.00536","journal-title":"Front Neurol"},{"key":"5479_CR52","doi-asserted-by":"publisher","DOI":"10.7916\/D84Q7T4W","volume":"5","author":"S Karkheiran","year":"2015","unstructured":"Karkheiran S, Shahidi GA, Walker RH, Pais\u00e1n-Ruiz C (2015) PLA2G6-associated dystonia\u2013parkinsonism: case report and literature review. Tremor Other Hyperkinet Mov 5:317. https:\/\/doi.org\/10.7916\/D84Q7T4W","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"5479_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ymgme.2014.03.008","volume":"112","author":"MA Illingworth","year":"2014","unstructured":"Illingworth MA, Meyer E, Chong WK et al (2014) PLA2G6-associated neurodegeneration (PLAN): further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease. Mol Genet Metab 112:183\u2013189. https:\/\/doi.org\/10.1016\/j.ymgme.2014.03.008","journal-title":"Mol Genet Metab"},{"issue":"7","key":"5479_CR54","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S1474-4422(19)30142-5","volume":"18","author":"T Klopstock","year":"2019","unstructured":"Klopstock T, Tricta F, Neumayr L, Karin I, Zorzi G, Fradette C, Kmie\u0107 T, B\u00fcchner B, et al (2019) Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. Lancet Neurol 18(7):631\u2013642. https:\/\/doi.org\/10.1016\/S1474-4422(19)30142-5","journal-title":"Lancet Neurol"},{"key":"5479_CR55","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/mds.23751","volume":"26","author":"G Zorzi","year":"2011","unstructured":"Zorzi G, Zibordi F, Chiapparini L et al (2011) Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial. Mov Disord 26:1756\u20131759. https:\/\/doi.org\/10.1002\/mds.23751","journal-title":"Mov Disord"},{"issue":"6","key":"5479_CR56","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.parkreldis.2014.03.002","volume":"20","author":"G Cossu","year":"2014","unstructured":"Cossu G, Abbruzzese G, Matta G, Murgia D, Melis M, Ricchi V, Galanello R, Barella S, et al (2014) Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up. Parkinsonism Relat Disord 20(6):651\u2013654. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.03.002","journal-title":"Parkinsonism Relat Disord"},{"key":"5479_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.629414","volume":"12","author":"V Iankova","year":"2021","unstructured":"Iankova V, Karin I, Klopstock T, Schneider SA (2021) Emerging disease-modifying therapies in neurodegeneration with brain iron accumulation (NBIA) disorders. Front Neurol 12:629414. https:\/\/doi.org\/10.3389\/fneur.2021.629414","journal-title":"Front Neurol"},{"issue":"1","key":"5479_CR58","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.661","volume":"11","author":"RVV Spaull","year":"2021","unstructured":"Spaull RVV, Soo AKS, Hogarth P, Hayflick SJ, Kurian MA (2021) Towards precision therapies for inherited disorders of neurodegeneration with brain iron accumulation. Tremor Other Hyperkinet Mov (N Y) 11(1):51. https:\/\/doi.org\/10.5334\/tohm.661","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"9","key":"5479_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184104","volume":"12","author":"C Arber","year":"2017","unstructured":"Arber C, Angelova PR, Wiethoff S, Tsuchiya Y, Mazzacuva F, Preza E, Bhatia KP, Mills K, et al (2017) iPSC-derived neuronal models of PANK2-associated neurodegeneration reveal mitochondrial dysfunction contributing to early disease. PLoS ONE 12(9):e0184104. https:\/\/doi.org\/10.1371\/journal.pone.0184104","journal-title":"PLoS ONE"},{"issue":"15","key":"5479_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154524","volume":"11","author":"N Romano","year":"2022","unstructured":"Romano N, Baiardi G, Pinto VM, Quintino S, Gianesin B, Sasso R, Diociasi A, Mattioli F, et al (2022) Long-term neuroradiological and clinical evaluation of NBIA patients treated with a deferiprone based iron-chelation therapy. J Clin Med 11(15):4524. https:\/\/doi.org\/10.3390\/jcm11154524","journal-title":"J Clin Med"},{"key":"5479_CR61","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1212\/01.wnl.0000310986.48286.8e","volume":"70","author":"MA Kurian","year":"2008","unstructured":"Kurian MA, Morgan NV, MacPherson L et al (2008) Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 70:1623\u20131629. https:\/\/doi.org\/10.1212\/01.wnl.0000310986.48286.8e","journal-title":"Neurology"},{"key":"5479_CR62","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/cells13161376","volume":"13","author":"F Agostini","year":"2024","unstructured":"Agostini F, Sgalletta B, Bisaglia M (2024) Iron dyshomeostasis in neurodegeneration with brain iron accumulation (NBIA): is it the cause or the effect? Cells 13:1376. https:\/\/doi.org\/10.3390\/cells13161376","journal-title":"Cells"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05479-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05479-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05479-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T13:05:27Z","timestamp":1763989527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05479-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5479"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05479-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"152"}}